Microvision Q3 2026 earnings
Record lidar revenue and consecutive quarter-over-quarter growth, supported by a 50% gross margin and a revised path to profitability.
Headline numbers
| Metric | Actual | YoY | QoQ | 8-K location |
|---|---|---|---|---|
| Revenue | $2.40M | +895% | +63% | Ex. 99.1, income statement |
Revenue breakdown
not stated in the 8-K
Margins and costs
- Gross margin 50.0% (prior 43.6%, change +6.4 pp)
- Operating expenses $22.54M (+60% YoY)
- One-offs in the quarter Settlement gain $1.74M; Restructuring charges $0.12M
- Effective tax rate 0.3% (prior-year 1.2%, year-to-date 0.5%)
- Non-GAAP bridge Adds back interest, taxes, depreciation, unrealized gains/losses, share-based compensation, inventory write-downs, acquisition-related costs, restructuring, and settlement gain.
KPIs
| Metric | Actual | Prior quarter | Prior year | Change |
|---|---|---|---|---|
| Cash and cash equivalents | $28.89M | $27.21M | $32.36M | +6.2% QoQ, -10.8% YoY |
| Gross margin | 50.0% | 43.6% | -297% | +6.4 pp QoQ |
| Revenue | $2.40M | $1.47M | $241K | +63% QoQ, +895% YoY |
Guidance
| Metric | Guide | Prior guide | Change |
|---|---|---|---|
| Full year 2026 revenue | $10M to $15M | $10M to $15M | No change |
| 2027 revenue | At least double 2026 level | — | — |
| 2027 operating cash burn | Approximately $40M | — | Reduction from current levels |
What drove it
- Revenue story Revenue grew 63% sequentially to $2.40M, driven by high customer demand and shipping to meet backlog.
- EPS story EPS improved YoY and QoQ due to revenue growth and margin expansion, despite higher operating expenses.
- One-off check Settlement gain of $1.74M and restructuring charges of $0.12M in Q3 2026.
The good
- Record lidar revenue
- 50% gross margin
- Consecutive quarter-over-quarter revenue growth
The bad
- Net loss of $12.23M
- Operating expenses increased 60% YoY
The ugly
- none
Open questions
- Specifics on the 'high customer demand' and 'purchase order backlog' driving the growth.
- Details on the 'significant fourth quarter cost reductions' to align resources with commercial drivers.
Full release
Microvision (MVIS) earnings release, October 28, 2026
Exhibit
99.1
MicroVision
Reports Third Quarter 2026 Results with Record Lidar Revenue and Accelerated Path to Profitability
Sustained revenue growth, shipping to meet high demand, confidence in 2026 revenue guidance, implemented cost reductions
ORLANDO,
Fla. – October 28, 2026 – MicroVision, Inc. (NASDAQ: MVIS), a leader in advanced perception solutions for industrial, security and defense, intelligent infrastructure, and automotive mobility, today announced its third quarter 2026 financial and operating results and reiterated full year 2026 revenue guidance based on high customer demand, purchase order backlog, and rapidly expanding shipping schedules. Significant fourth quarter cost reductions align operating resources with commercial drivers and bring forward the path to profitability.
Third quarter progress included continued quarter-over-quarter revenue growth and 50% gross margins, new defense programs including Overland
AI, an exclusive strategic alliance bringing immediate ITS revenue and Blue-Band commercial contracts, and Scantinel’s entry into high-speed optical connectivity for AI data centers.
“MicroVision’s commercial transformation is here, with record lidar sales and another consecutive quarter of revenue growth,” said Glen DeVos,
Chief Executive Officer of MicroVision. “As expected, we’ve seen customer demand for IRIS™ sensors grow significantly in the second half of this year and, combined with our production launch of MOVIA™ Pro earlier this month, we are now actively delivering on a backlog of purchase orders to meet urgent demand from customers.”
“As we continue to drive near- and medium-term revenue growth, we have implemented a plan to significantly reduce operating expenses and cash burn,” said Christine Chambers, Chief Financial Officer of MicroVision. “Laser-focused on our path to profitability, we are ensuring that our resources are directly aligned with key revenue drivers. As we look to 2027, we see a clear path to continued revenue growth and a reduction in cash burn to $40 million for the year.”
Third
Quarter 2026 Financial Highlights
“MicroVision’s financial priorities remain centered on disciplined capital allocation, improved operating efficiency, and converting commercial opportunities into sustainable revenue,” said Chambers. “We are focused on managing costs, improving cash efficiency, and directing investments toward programs with the clearest potential to support our growth and profitability objectives.”
Third
Quarter 2026 Business and Operational Highlights
Advanced
Commercial Momentum Across Multiple End Markets
“As we advance our commercial strategy, we must operate with focus, precision, and accountability,” said DeVos. “That means making deliberate decisions about where we invest our people, capital, and capabilities. We are aligning our organization around the opportunities where we believe we can create the greatest impact and deliver the strongest commercial returns. This is about building the right organization for MicroVision’s next phase of growth, one that is structured to execute efficiently, respond to customer needs, and translate our technology investments into sustainable business performance.”
Financial
Outlook
MicroVision continues to execute against its commercial growth strategy while prioritizing financial discipline and a more efficient operating model.
Full year 2026 revenue outlook remains in the range of $10 million to $15 million, with 2027 revenue expected to at least double from our expected 2026 level.
The company expects to reduce operating cash burn to approximately $40 million in 2027, a reduction of roughly one-third from current levels.
As
MicroVision moves into 2027, its strategic priorities remain focused on accelerating revenue growth and operating cost optimization.
Conference
Call and Webcast
MicroVision will host a conference call and webcast on October 28, 2026, at 4:30 p.m. Eastern Time to discuss its third quarter 2026 financial and operating results.
The webcast and accompanying presentation materials will be available on the Company’s Investor Relations website at ir.microvision.com.
A replay of the webcast will be available following the event.
About
MicroVision
MicroVision is defining the next generation of lidar-based perception solutions for industrial, security & defense, and automotive markets. As the industry moves beyond proof of concept toward value, deployment, and commercialization, MicroVision delivers integrated hardware and software solutions designed for real-world performance, automotive-grade reliability, and economic scalability. With engineering centers in the U.S. and Germany, MicroVision leads the industry in depth and breadth of its portfolio, with both short- and long-range lidar solutions, featuring solid-state sensors with varying wavelengths, advanced sensor architectures, design-to-cost engineering, and open software solutions.
For more information, visit www.microvision.com,
Facebook, and
LinkedIn.
MicroVision,
MicroVision HALO, IRIS, MOVIA, MOSAIK, and SENTINEL are trademarks of MicroVision, Inc., and SCANTINEL is a trademark of Scantinel GmbH, in the United States and other countries. All other trademarks are the property of their respective owners.
Non-GAAP
Information
To supplement MicroVision’s condensed financial statements presented in accordance with GAAP, the Company presents investors with the non-GAAP financial measures “adjusted EBITDA” and “adjusted Gross Profit.” Adjusted EBITDA consists of GAAP net income (loss) excluding the impact of the following: interest income and interest expense; income tax expense; depreciation and amortization; non-cash gains and losses; share-based compensation; restructuring costs; acquisition-related costs; impairment charges; and settlement... (truncated)lculated as GAAP gross profit before share-based compensation expense, inventory write downs, and the amortization of acquired intangibles included in cost of revenue.
MicroVision believes that the presentation of adjusted EBITDA and adjusted Gross Profit provides important supplemental information to management and investors regarding financial and business trends, provides consistency and comparability with MicroVision’s past financial reports, and facilitates comparisons with other companies in the Company’s industry, many of which use similar non-GAAP financial measures to supplement their GAAP results. Internally, management uses these non-GAAP measures when evaluating operating performance because the exclusion of the items described above provides an additional useful measure of the Company’s operating results and facilitates comparisons of the Company’s core operating performance against prior periods and its business objectives. Externally, the Company believes that adjusted EBITDA and adjusted Gross Profit are useful to investors in their assessment of MicroVision’s operating performance and the valuation of the Company.
Adjusted
EBITDA and adjusted Gross Profit are not calculated in accordance with GAAP, and should be considered supplemental to, and not as a substitute for, or superior to, financial measures calculated in accordance with GAAP. Non-GAAP financial measures have limitations in that they do not reflect all of the costs associated with the operations of MicroVision’s business as determined in accordance with GAAP.
The Company expects to continue to incur expenses similar to the non-GAAP adjustments described above, and exclusion of these items from its non-GAAP financial measures should not be construed as an inference that these costs are unusual or infrequent.
The
Company compensates for limitations of the adjusted EBITDA measure by prominently disclosing GAAP net income (loss), which the Company believes is the most directly comparable GAAP measure, and providing investors with a reconciliation from GAAP net income (loss) to adjusted
EBITDA.
Similarly for adjusted Gross Profit, the Company compensates for limitations of the measure by prominently disclosing GAAP gross profit which is the difference between Revenue and Cost of revenue, which the Company believes is the most directly comparable GAAP measure, and providing investors with a reconciliation by backing out share-based compensation expense and the amortization of acquired intangibles included in cost of revenue.
Forward-Looking
Statements
Financial statements
Income Statement
Three months ended September 30, — (In thousands, except per share data)
| Three months ended September 30, – 2026 | Three months ended September 30, – 2025 | Nine months ended September 30, – 2026 | Nine months ended September 30, – 2025 | |
|---|---|---|---|---|
| Revenue | 2,400 | 241 | 4,808 | 985 |
| Cost of revenue | 1,201 | 957 | 2,604 | 2,223 |
| Gross profit (loss) | 1,199 | -716 | 2,204 | -1,238 |
| Research and development expense | 13,180 | 7,978 | 43,327 | 23,039 |
| Sales, marketing, general and administrative expense | 9,359 | 4,027 | 28,081 | 17,140 |
| Impairment loss on operating lease right-of-use assets | 9 | |||
| Gain on disposal of fixed assets | -3 | -171 | ||
| Total operating expenses | 22,536 | 12,005 | 71,246 | 40,179 |
| Loss from operations | -21,337 | -12,721 | -69,042 | -41,417 |
| Interest expense | -1,907 | -2,197 | -10,140 | -17,270 |
| Unrealized gain (loss) on derivative liability | -491 | 1,059 | -5,146 | 3,853 |
| Unrealized gain (loss) on warrant liability | 3,566 | -326 | 5,061 | 2,238 |
| Realized loss on debt extinguishment | -3,083 | -4,654 | ||
| Bargain purchase gain | 147 | |||
| Other income | 7,974 | 140 | 8,134 | 363 |
| Net loss before taxes | -12,195 | -14,045 | -74,069 | -56,887 |
| Income tax expense | -33 | -172 | -396 | -338 |
| Net loss | -12,228 | -14,217 | -74,465 | -57,225 |
| Net loss per share - basic and diluted | -0.45 | -0.72 | -3.18 | -3.27 |
| Weighted-average shares outstanding - basic and diluted | 27,388 | 19,697 | 23,445 | 17,482 |
Income Statement
Three months ended September 30, — (In thousands)
| Three months ended September 30, – 2026 | Three months ended September 30, – 2025 | Nine months ended September 30, – 2026 | Nine months ended September 30, – 2025 | |
|---|---|---|---|---|
| Reconciliation of Non-GAAP Gross Profit (Loss): | ||||
| Gross profit | 1,199 | -716 | 2,204 | -1,238 |
| Inventory related write-downs | 64 | 116 | ||
| Amortization of acquired intangibles | 290 | 652 | ||
| Adjusted Gross Profit (Loss) | 1,263 | -426 | 2,320 | -586 |
| GAAP Net loss | -12,228 | -14,217 | -74,465 | -57,225 |
| Interest expense, net | 1,907 | 2,057 | 10,140 | 16,907 |
| Provision for income taxes | 33 | 172 | 396 | 338 |
| Depreciation and amortization | 2,930 | 1,395 | 8,274 | 4,347 |
| Unrealized (gain) loss on derivative liability | 491 | -1,059 | 5,146 | -3,853 |
| Unrealized (gain) loss on warrant liability | -3,566 | 326 | -5,061 | -2,238 |
| Loss on debt extinguishment | 3,083 | 4,654 | ||
| Gain on disposal of fixed assets | -3 | -171 | ||
| Impairment of operating lease right-of-use assets | 9 | |||
| Share-based compensation expense | 1,162 | -1,603 | 3,449 | 2,248 |
| Inventory related write-downs | 64 | 116 | ||
| Settlement gain | -1,740 | -1,740 | ||
| Acquisition-related costs | 2,870 | |||
| Restructuring charges | -116 | 1,202 | 1,023 | 1,202 |
| Adjusted EBITDA | -11,066 | -11,727 | -46,931 | -33,620 |
Balance Sheet
September 30, — (In thousands)
| September 30, – 2026 | December 31, – 2025 | |
|---|---|---|
| Current assets | ||
| Cash and cash equivalents | 28,890 | 32,363 |
| Investment securities, available-for-sale | 42,471 | |
| Restricted cash, current | 264 | 497 |
| Accounts receivable, net of allowances | 1,404 | 47 |
| Inventory | 4,403 | 745 |
| Other current assets | 2,887 | 4,989 |
| Total current assets | 37,848 | 81,112 |
| Property and equipment, net | 15,736 | 4,280 |
| Operating lease right-of-use assets | 16,840 | 14,075 |
| Restricted cash, net of current portion | 1,182 | 1,204 |
| Intangible assets, net | 13,358 | 32 |
| Goodwill | 3,677 | |
| Other assets | 2,188 | 2,416 |
| Total assets | 90,829 | 103,119 |
| Current liabilities | ||
| Accounts payable | 6,356 | 1,628 |
| Accrued liabilities | 5,664 | 5,426 |
| Deferred revenue | 132 | |
| Derivative liability | 6,331 | |
| Notes payable | 22,595 | 19,212 |
| Operating lease liabilities, current | 5,243 | 3,481 |
| Finance lease liabilities, current | 12 | 14 |
| Other current liabilities | 805 | 388 |
| Total current liabilities | 47,138 | 30,149 |
| Warrant liability | 4,928 | 1,875 |
| Operating lease liabilities, net of current portion | 14,682 | 14,034 |
| Finance lease liabilities, net of current portion | 14 | 27 |
| Other long-term liabilities | 1,321 | 1,486 |
| Total liabilities | 68,083 | 47,571 |
| Shareholders’ equity | ||
| Common stock at par value | 33 | 20 |
| Additional paid-in capital | 1,053,830 | 1,012,121 |
| Accumulated other comprehensive income | 610 | 669 |
| Accumulated deficit | -1,031,727 | -957,262 |
| Total shareholders’ equity | 22,746 | 55,548 |
| Total liabilities and shareholders’ equity | 90,829 | 103,119 |
Cash Flow
From the 10-Q · (Unaudited) (in thousands)
| 2026 – Nine Months Ended – September 30, | 2025 – Nine Months Ended – September 30, | |
|---|---|---|
| Cash flows from operating activities | ||
| Net loss | -74,465 | -57,225 |
| Adjustments to reconcile net loss to net cash used in operations: | ||
| Depreciation and amortization | 8,274 | 4,347 |
| Unrealized (gain) loss on derivative liability | 5,146 | -3,853 |
| Unrealized gain on warrant liability | -5,061 | -2,238 |
| Loss on debt extinguishment | 3,083 | 4,654 |
| Bargain purchase gain | -147 | |
| Gain on disposal of fixed assets | -171 | |
| Impairment of operating lease right-of-use assets | 9 | |
| Inventory write-downs | 116 | |
| Non-cash interest expense | 7,325 | |
| Amortization of debt discount and issuance costs on notes payable | 10,105 | 9,915 |
| Share-based compensation expense | 3,449 | 2,248 |
| Net accretion of premium on short-term investments | -81 | -284 |
| Change in: | ||
| Accounts receivable | -1,357 | 886 |
| Inventory | 26 | -5,798 |
| Other current and non-current assets | 355 | -2,170 |
| Accounts payable | 4,525 | 207 |
| Accrued liabilities | 238 | 1,087 |
| Contract liabilities and other current liabilities | 549 | 32 |
| Operating lease liabilities | -3,697 | -2,188 |
| Other long-term liabilities | -120 | -260 |
| Net cash used in operating activities | -49,224 | -43,315 |
Certain statements contained in this release, including market position, expectations, and likelihood of success; opportunities for customer engagement and revenue; expense reduction; benefits of acquisitions and integration synergies; market position; product portfolio; product and manufacturing capabilities; access to capital and capital-raising opportunities; and expected revenue, expenses and cash usage are forward-looking statements that involve a number of risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. Factors that could cause actual results to differ materially from those projected in such forward-looking statements include the risk its ability to operate with limited cash or to raise additional capital when needed; market acceptance of its technologies and products or for products incorporating its technologies; the failure of its commercial partners to perform as expected under its agreements; its financial and technical resources relative to those of its competitors; its ability to keep up with rapid technological change; government regulation of its technologies; its ability to enforce its intellectual property rights and protect its proprietary technologies; the ability to obtain customers and develop partnership opportunities; the timing of commercial product launches and delays in product development; the ability to achieve key technical milestones in key products; dependence on third parties to develop, manufacture, sell and market its products; potential product liability claims; its ability to maintain its listing on The Nasdaq Stock Market, and other risk factors identified from time to time in the Company’s SEC reports, including the Company’s Annual Report on Form
10-K, Quarterly Reports on Form 10-Q and other reports filed with the SEC. These factors are not intended to represent a complete list of the general or specific factors that may affect the Company. It should be recognized that other factors, including general economic factors and business strategies, may be significant, now or in the future, and the factors set forth in this release may affect the Company to a greater extent than indicated. Except as expressly required by federal securities laws, the Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, changes in circumstances or any other reason.
Investor
Relations Contact
Jeff
Christensen
Darrow
Associates Investor Relations
MVIS@darrowir.com
Media
Contact
Heidi
Davidson – For MicroVision heidi@galvanizeworldwide.com
(914)
441-6862
MicroVision,
Inc.
Consolidated
Balance Sheets
(In thousands)
MicroVision,
Inc.
Consolidated
Statement of Operations
(In thousands, except per share data)
MicroVision,
Inc.
Consolidated
Statements of Cash Flows
(In thousands)
The following table provides a reconciliation of the cash, cash equivalents, and restricted cash balances as of September 30, 2026 and 2025:
MicroVision,
Inc.
Reconciliation of GAAP to Non-GAAP Measures
(In thousands)